↓ Skip to main content

Treatment with rituximab and brentuximab vedotin in a patient of common variable immune deficiency-associated classic Hodgkin lymphoma

Overview of attention for article published in Biomarker Research, March 2016
Altmetric Badge

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
12 Mendeley